{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T16:33:38Z","timestamp":1717778018651},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T00:00:00Z","timestamp":1268179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s00296-009-1343-3","type":"journal-article","created":{"date-parts":[[2010,3,9]],"date-time":"2010-03-09T11:05:42Z","timestamp":1268132742000},"page":"785-794","source":"Crossref","is-referenced-by-count":11,"title":["Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"31","author":[{"given":"Xue","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,10]]},"reference":[{"key":"1343_CR1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","volume":"41","author":"RC Lawrence","year":"1998","unstructured":"Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, Heyse SP, Hirsch R, Hochberg MC, Hunder GG, Liang MH, Pillemer SR, Steen VD, Wolfe F (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41:778\u2013799","journal-title":"Arthritis Rheum"},{"key":"1343_CR2","first-page":"421","volume":"21","author":"GL Wei","year":"2008","unstructured":"Wei GL, Ding Y, Han YX, Chen JL, Xu LH, Yong YH, Yang ZY (2008) Preparation of ELISA kit for quantitative determination of antibody against cyclic citrullinated peptide and its significance in diagnosis of rheumatoid arthritis. Chin J Biologicals 21:421\u2013424","journal-title":"Chin J Biologicals"},{"key":"1343_CR3","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/art.10195","volume":"46","author":"TW Huizinga","year":"2002","unstructured":"Huizinga TW, MacHold KP, Breedveld FC, Lipsky PE, Smolen JS (2002) Criteria for early rheumatoid arthritis: from Bayes\u2019 law revisited to new thoughts on pathogenesis. Arthritis Rheum 46:1155\u20131159","journal-title":"Arthritis Rheum"},{"key":"1343_CR4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"1343_CR5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.10241","volume":"47","author":"A Saraux","year":"2002","unstructured":"Saraux A, Berthelot JM, Chal\u00e8s G, Le Henaff C, Mary JY, Thorel JB, Hoang S, Dueymes M, Allain J, Devauchelle V, Baron D, Le Goff P, Youinou P (2002) Value of laboratory tests in early prediction of rheumatoid arthritis. Arthritis Rheum 47:155\u2013165","journal-title":"Arthritis Rheum"},{"key":"1343_CR6","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar2011","volume":"8","author":"BV Cruyssen","year":"2006","unstructured":"Cruyssen BV, Cantaert T, Nogueira L, Clavel C, Rycke LD, Dendoven A, Dendoven A, Sebag M, Deforce D, Vincent C, Elewaut D, Serre G, De Keyser F (2006) Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Arthritis Res Ther 8:R122","journal-title":"Arthritis Res Ther"},{"key":"1343_CR7","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI117969","volume":"95","author":"M Sebbag","year":"1995","unstructured":"Sebbag M, Simon M, Vincent C, Masson-Bessi\u00e8re C, Girbal E, Durieux JJ, Serre G (1995) The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 95:2672\u20132679","journal-title":"J Clin Invest"},{"key":"1343_CR8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","volume":"162","author":"E Girbal-Neuhauser","year":"1999","unstructured":"Girbal-Neuhauser E, Durieux JJ, Arnaud M, Dalbon P, Sebbag M, Vincent C, Simon M, Senshu T, Masson-Bessi\u00e8re C, Jolivet-Reynaud C, Jolivet M, Serre G (1999) The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 162:585\u2013594","journal-title":"J Immunol"},{"key":"1343_CR9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"GA Schellekens","year":"1998","unstructured":"Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis specific autoantibodies. J Clin Invest 101:273\u2013281","journal-title":"J Clin Invest"},{"key":"1343_CR10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14767050500134217","volume":"12","author":"M Herold","year":"2005","unstructured":"Herold M, Boeser V, Russe E, Klotz W (2005) Anti-CCP: history and its usefulness. Clin Dev Immunol 12:131\u2013135","journal-title":"Clin Dev Immunol"},{"key":"1343_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing acyclic citrullinated peptide. Arthritis Rheum 43:155\u2013163","journal-title":"Arthritis Rheum"},{"key":"1343_CR12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/ard.2003.019877","volume":"63","author":"I Vallbracht","year":"2004","unstructured":"Vallbracht I, Rieber J, Oppermann M, F\u00f6rger F, Siebert U, Helmke K (2004) Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 63:1079\u20131084","journal-title":"Ann Rheum Dis"},{"key":"1343_CR13","first-page":"2535","volume":"30","author":"A Saraux","year":"2003","unstructured":"Saraux A, Berthelot JM, Devauchelle V, Bendaoud B, Chal\u00e8s G, Le Henaff C, Thorel JB, Hoang S, Jousse S, Baron D, Le Goff P, Youinou P (2003) Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis. J Rheumatol 30:2535\u20132539","journal-title":"J Rheumatol"},{"key":"1343_CR14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cair.2003.11.001","volume":"4","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar ER, Venrooij WJ (2004) Anti-CCP antibodies, a specific marker for (early) rheumatoid arthritis. Clin Appl Immunol Rev 4:239\u2013262","journal-title":"Clin Appl Immunol Rev"},{"key":"1343_CR15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10165-004-0325-2","volume":"14","author":"Y Takasaki","year":"2004","unstructured":"Takasaki Y, Yamanaka K, Takasaki C, Matsushita M, Yamada H, Nawata M, Matsudaira R, Ikeda K, Kaneda K, Hashimoto H (2004) Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease. Mod Rheumatol 14:367\u2013375","journal-title":"Mod Rheumatol"},{"key":"1343_CR16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/ard.2006.058933","volume":"66","author":"A Vannini","year":"2007","unstructured":"Vannini A, Cheung K, Fusconi M, Stammen-Vogelzangs J, Drenth JP, Dall\u2019Aglio AC, Bianchi FB, Bakker-Jonges LE, van Venrooij WJ, Pruijn GJ, Zendman AJ (2007) Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? Ann Rheum Dis 66:511\u2013516","journal-title":"Ann Rheum Dis"},{"key":"1343_CR17","first-page":"1027","volume":"21","author":"N Despres","year":"1994","unstructured":"Despres N, Boire G, Lopez-Longo FJ, M\u00e9nard HA (1994) The Sa system: a novel antigen\u2013antibody system specific for rheumatoid arthritis. J Rheumatol 21:1027\u20131033","journal-title":"J Rheumatol"},{"key":"1343_CR18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/ar1171","volume":"6","author":"HS El-Gabalawy","year":"2004","unstructured":"El-Gabalawy HS, Wilkins JA (2004) Anti-Sa antibodies: prognostic and pathogenetic significance to rheumatoid arthritis. Arthritis Res Ther 6:86\u201389","journal-title":"Arthritis Res Ther"},{"key":"1343_CR19","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","volume":"6","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar ER, Despres N, Lapointe E, van der Heijden A, Lora M, Senshu T, van Venrooij WJ, M\u00e9nard HA (2004) Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 6:R142\u2013R150","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1343_CR20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar93","volume":"2","author":"R Goldbach-Mansky","year":"2000","unstructured":"Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, Steiner G, Rosen A, Zhang C, M\u00e9nard HA, Zhou ZJ, Palosuo T, Van Venrooij WJ, Wilder RL, Klippel JH, Schumacher HR Jr, El-Gabalawy HS (2000) Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2(3):236\u2013243","journal-title":"Arthritis Res"},{"key":"1343_CR21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/ar2008","volume":"8","author":"C Dejaco","year":"2006","unstructured":"Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M (2006) Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Arthritis Res Ther 8:119","journal-title":"Arthritis Res Ther"},{"key":"1343_CR22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-2-9","volume":"2","author":"WL Devill\u00e9","year":"2002","unstructured":"Devill\u00e9 WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der Windt DA, Bezemer PD (2002) Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2:9","journal-title":"BMC Med Res Methodol"},{"key":"1343_CR23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-3-25","volume":"3","author":"P Whiting","year":"2003","unstructured":"Whiting P, Rutjes AW, Reitsma JB, Reitsma J, Bossuyt PM, Kleijnen J (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3:25","journal-title":"BMC Med Res Methodol"},{"key":"1343_CR24","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","volume":"56","author":"AS Glas","year":"2003","unstructured":"Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56:1129\u20131135","journal-title":"J Clin Epidemiol"},{"key":"1343_CR25","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/sim.4780121403","volume":"12","author":"LE Moses","year":"1993","unstructured":"Moses LE, Shapiro D, Littenberg B (1993) Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12:1293\u20131316","journal-title":"Stat Med"},{"key":"1343_CR26","doi-asserted-by":"crossref","unstructured":"Deeks JJ (2001) Systematic reviews of evaluation of diagnostic and screening tests. In: Egger M, Davey-Smith G, Altmann DG (eds) Systematic reviews in health care: meta-analysis in context. BMJ, London, pp 248\u2013282","DOI":"10.1002\/9780470693926.ch14"},{"key":"1343_CR27","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"1343_CR28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jclinepi.2003.09.017","volume":"57","author":"S Suzuki","year":"2004","unstructured":"Suzuki S, Moro-oka T, Choudhry NK (2004) The conditional relative odds ratio provided less biased results for comparing diagnostic test accuracy in meta-analyses. J Clin Epidemiol 57:461\u2013469","journal-title":"J Clin Epidemiol"},{"key":"1343_CR29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"1343_CR30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1373\/clinchem.2006.078063","volume":"53","author":"D Coenen","year":"2007","unstructured":"Coenen D, Verschueren P, Westhovens R, Bossuyt X (2007) Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein\/peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Chem 53:498\u2013504","journal-title":"Clin Chem"},{"key":"1343_CR31","first-page":"1658","volume":"34","author":"L So\u00f3s","year":"2007","unstructured":"So\u00f3s L, Szekanecz Z, Szab\u00f3 Z, Fekete A, Zeher M, Horv\u00e1th IF, Dank\u00f3 K, Kapit\u00e1ny A, V\u00e9gv\u00e1ri A, Sipka S, Szegedi G, Lakos G (2007) Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. J Rheumatol 34:1658\u20131663","journal-title":"J Rheumatol"},{"key":"1343_CR32","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.22817","volume":"56","author":"H Bang","year":"2007","unstructured":"Bang H, Egerer K, Gauliard A, L\u00fcthke K, Rudolph PE, Fredenhagen G, Berg W, Feist E, Burmester GR (2007) Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum 56:2503\u20132511","journal-title":"Arthritis Rheum"},{"key":"1343_CR33","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1373\/clinchem.2007.087569","volume":"53","author":"N Bizzaro","year":"2007","unstructured":"Bizzaro N, Tonutti E, Tozzoli R, Villalta D (2007) Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins. Clin Chem 53:1527\u20131533","journal-title":"Clin Chem"},{"key":"1343_CR34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4078\/jkra.2007.14.3.235","volume":"14","author":"JS Song","year":"2007","unstructured":"Song JS, Park GB, Park AJ (2007) Comparison of anti-mutated citrullinated vimentin with anti-cyclic citrullinated peptide and rheumatoid factors for the diagnostic value of rheumatoid arthritis. Korean Rheum Assoc 14:235\u2013241","journal-title":"Korean Rheum Assoc"},{"key":"1343_CR35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12016-007-8016-3","volume":"34","author":"H Poulsom","year":"2008","unstructured":"Poulsom H, Charles PJ (2008) Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis. Clin Rev Allergy Immunol 34:4\u201310","journal-title":"Clin Rev Allergy Immunol"},{"key":"1343_CR36","first-page":"1002","volume":"35","author":"L Innala","year":"2008","unstructured":"Innala L, Kokkonen H, Eriksson C, Jidell E, Berglin E, Dahlqvst SR (2008) Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24\u00a0months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides. J Rheumatol 35:1002\u20131008","journal-title":"J Rheumatol"},{"key":"1343_CR37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/ar2362","volume":"10","author":"J Ursum","year":"2008","unstructured":"Ursum J, Nielen MM, van Schaardenburg D, van der Horst AR, van de Stadt RJ, Dijkmans BA, Hamann D (2008) Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study. Arthritis Res Ther 10:12","journal-title":"Arthritis Res Ther"},{"key":"1343_CR38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/art.23188","volume":"58","author":"L Mathsson","year":"2008","unstructured":"Mathsson L, Mullazehi M, Wick MC, Sj\u00f6berg O, van Vollenhoven R, Klareskog L, R\u00f6nnelid J (2008) Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum 58:36\u201345","journal-title":"Arthritis Rheum"},{"key":"1343_CR39","doi-asserted-by":"crossref","unstructured":"Wagner E, Skoumal M, Bayer PM, Klaushofer K (2009) Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis. Rheumatol Int. Available at http:\/\/www.springerlink.com\/content\/8232g31958731036\/ (published online)","DOI":"10.1007\/s00296-009-0854-2"},{"key":"1343_CR40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3899\/jrheum.080656","volume":"36","author":"N Mutlu","year":"2009","unstructured":"Mutlu N, Bicakcigil M, Tasan DA, Kaya A, Yavuz S, Ozden AI (2009) Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis. J of Rheum 36:491\u2013500","journal-title":"J of Rheum"},{"key":"1343_CR41","first-page":"686","volume":"10","author":"R Feng","year":"2006","unstructured":"Feng R, YZ LI, Zhao GF, Jiang M (2006) The diagnostic value of anti-mutated citrullinated vimentin antibody in patients with rheumatoid arthritis. Chin J Rheumatol 10:686\u2013689","journal-title":"Chin J Rheumatol"},{"key":"1343_CR42","first-page":"1160","volume":"23","author":"YM Jiang","year":"2008","unstructured":"Jiang YM, Jiang DL, Pan YH, Sun JM (2008) Diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis. Clin Focus 23:1160\u20131162","journal-title":"Clin Focus"},{"key":"1343_CR43","first-page":"676","volume":"36","author":"HP Xu","year":"2008","unstructured":"Xu HP, Qi WC, Qi WF (2008) The diagnostic value of the antibodies against mutated citrullinated vimentin in patients with rheumatoid arthritis. Tianjin Med J 36:676\u2013678","journal-title":"Tianjin Med J"},{"key":"1343_CR44","first-page":"305","volume":"21","author":"JR Song","year":"2008","unstructured":"Song JR, Yu QH (2008) The early diagnostic value of the antibodies against mutated citrullinated vimentin in patients with rheumatoid arthritis. Sheng Yang Bu Dui Yi Yao 21:305\u2013306","journal-title":"Sheng Yang Bu Dui Yi Yao"},{"key":"1343_CR45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar93","volume":"2","author":"R Goldbach-Mansky","year":"2000","unstructured":"Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, Steiner G, Rosen A, Zhang C, M\u00e9nard HA, Zhou ZJ, Palosuo T, Van Venrooij WJ, Wilder RL, Klippel JH, Schumacher HR Jr, El-Gabalawy HS (2000) Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2:236\u2013243","journal-title":"Arthritis Res"},{"key":"1343_CR46","first-page":"2208","volume":"22","author":"C Egsmose","year":"1995","unstructured":"Egsmose C, Lund B, Borg G, Pettersson H, Berg E, Brodin U, Trang L (1995) Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5\u00a0year follow-up of a prospective double blind placebo controlled study. J Rheumatol 22:2208\u20132213","journal-title":"J Rheumatol"},{"key":"1343_CR47","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.rdc.2005.07.008","volume":"31","author":"MA Quinn","year":"2005","unstructured":"Quinn MA, Emery P (2005) Potential for altering rheumatoid arthritis outcome. Rheum Dis Clin North Am 31:763\u2013772","journal-title":"Rheum Dis Clin North Am"},{"key":"1343_CR48","first-page":"1072","volume":"25","author":"DP Symmons","year":"1998","unstructured":"Symmons DP, Jones MA, Scott DL, Prior P (1998) Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol 25:1072\u20131077","journal-title":"J Rheumatol"},{"key":"1343_CR49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bmj.323.7305.157","volume":"323","author":"JJ Deeks","year":"2001","unstructured":"Deeks JJ (2001) Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ 323:157\u2013162","journal-title":"BMJ"},{"key":"1343_CR50","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-120-8-199404150-00008","volume":"120","author":"L Irwig","year":"1994","unstructured":"Irwig L, Tosteson AN, Gatsonis C, Lau J, Colditz G, Chalmers TC, Mosteller F (1994) Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 120:667\u2013676","journal-title":"Ann Intern Med"},{"key":"1343_CR51","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455\u2013463","journal-title":"Biometrics"},{"key":"1343_CR52","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1002\/sim.1091","volume":"20","author":"DB Petitti","year":"2001","unstructured":"Petitti DB (2001) Approaches to heterogeneity in meta-analysis. Stat Med 20:3625\u20133633","journal-title":"Stat Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-009-1343-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1343-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T20:30:38Z","timestamp":1685478638000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-009-1343-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,10]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["1343"],"URL":"https:\/\/doi.org\/10.1007\/s00296-009-1343-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,10]]}}}